Patients with pre-existing rheumatoid arthritis receiving immune checkpoint inhibitors for malignancy experience severe immune related Adverse Events (irAEs) at a similar rate to other cancer patients without autoimmune diseases. A study of 84 RA patients with cancers such as melanoma and non-small cell lung cancer and pre-existing autoimmune conditions found 41% of patients developed irAEs ...
Don’t deny RA patients cancer immunotherapy
By Mardi Chapman
13 Nov 2019